Correlation Between Bausch Health and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Bausch Health and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bausch Health Companies and MAIA Biotechnology, you can compare the effects of market volatilities on Bausch Health and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and MAIA Biotechnology.
Diversification Opportunities for Bausch Health and MAIA Biotechnology
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bausch and MAIA is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Bausch Health i.e., Bausch Health and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Bausch Health and MAIA Biotechnology
Considering the 90-day investment horizon Bausch Health Companies is expected to generate 0.63 times more return on investment than MAIA Biotechnology. However, Bausch Health Companies is 1.59 times less risky than MAIA Biotechnology. It trades about 0.17 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.06 per unit of risk. If you would invest 607.00 in Bausch Health Companies on August 31, 2024 and sell it today you would earn a total of 230.00 from holding Bausch Health Companies or generate 37.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Bausch Health Companies vs. MAIA Biotechnology
Performance |
Timeline |
Bausch Health Companies |
MAIA Biotechnology |
Bausch Health and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bausch Health and MAIA Biotechnology
The main advantage of trading using opposite Bausch Health and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.The idea behind Bausch Health Companies and MAIA Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |